GARRISON RICHARD C 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 6, 2009
Insider Transaction Report
Form 4
GARRISON RICHARD C
SVP and Catalyst
Transactions
- Award
Stock Option
2009-02-05+45,750→ 45,750 totalExercise: $33.55From: 2009-05-05Exp: 2019-02-04→ Common Stock (45,750 underlying) - Award
Common Stock
2009-02-05$0.01/sh+10,166$102→ 37,437 total
Holdings
- 799(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Stock grant made under 2006 Stock and Option Plan, vesting on 2/5/2013, subject to 50% acceleration upon filing a new drug application with the FDA for telaprevir and 50% acceleration upon the approval of a new drug application for telaprevir.
- [F2]Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/09.